Continuity of Care (Tablet Program)

Recovery doesn’t end at the hospital door. That’s usually where it gets hardest. This program sends each mental-health patient home with a tablet that keeps the ward with them, so a hard week gets noticed while it’s still just a hard week.

Target: ₪ $45,000

150 patients Cared for
$300 a patient For a year
1 secure channel No internet

Well enough to leave, but not yet well enough to be out of reach. This is how someone keeps looking, across the distance between better and well.

Well enough to leave, but not to manage

Patients are discharged because they're doing well. But they leave a place where a clinician looked in every few hours, for a life that has to be rebuilt piece by piece, often with the next appointment weeks away. Each week they sit down again with the same clinicians who treated them, who know their history and can hear when something in their voice has changed.

One connection

The tablet opens onto a single secure channel to the clinical team, with no internet behind it. For the many patients here from the ultra-Orthodox community, where bringing a screen into the home is a serious decision, this is what makes it possible. A family can accept the care without weighing what else might come with it.

Continuity is the treatment…

Everything in the ward is built to hold. This funds the part that holds it afterwards: the weekly contact that catches a warning sign in week two, instead of meeting the same patient again in crisis in week six. Recovery rarely fails all at once. It slips when no one is looking.

“Gentlemen, I do not come here to compete. I come here to complete.”

— Dr. Moshe Rothschild z”l, Founder

Every department at Mayanei Hayeshua began because a person needed care. A mother who would have travelled hours. A child who would have waited too long. A family who wouldn’t feel understood and embraced elsewhere.

FUNDING THE EXPANSION

Dr Rothschild filled those gaps one by one, and never stopped. And his legacy lives on. This unit is the next one. It doesn’t need a founder anymore — it needs you.

Target

₪ $45,000

150 tablets, programmed and secured, with the follow-up system behind them. $300 a patient, for a year of staying in treatment, and for the readmission that never has to happen.